EVENTS:   The Roaring 2020s or a Rerun of the 1970s? - Edward Yardeni/Yardeni Research - 24 Mar 26   Best Equity Short Ideas Conference Call 13 - Thomas Chanos/Badger Consultants & Dr. Aaron Fletcher/Bios Research & Jonathan Telgener/Channel Dynamics & Ed Steele/Iron Blue Financials & John Zolidis/Quo Vadis Capital & Mark Hiley/The Analyst - 26 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Filters

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

BAM Group (BAMNB NA) Netherlands

Industrials

the IDEA!

FY23 results were well ahead of market consensus following an impressive final quarter. Ahead of BAM's CMD, the company unveiled its main financial targets for 2024 to 2026. Besides an adjusted EBITDA margin of between 4-6%, it targets revenue of €6bn+, capital ratio of c.25% and a return to shareholders consisting of a dividend amounting to 30-50% of net income from operations (8% dividend yield) and additional cash returns via share buybacks. the IDEA! argues BAM’s mid-term financial targets are not overly ambitious and reiterates their view that the stock is significantly undervalued.

Edition: 180

- 23 February, 2024